Completed PHASE2 INTERVENTIONAL 3-arm NCT01165372

Study of Malaria Treatment at Phuoc Long Hospital, Binh Phuoc Province, Vietnam

Clinical Investigation of In-vivo Susceptibility of P. Falciparum to Artesunate in Phuoc Long Hospital, Binh Phuoc Province, Vietnam

Sponsor: Oxford University Clinical Research Unit, Vietnam

Conditions Malaria

Interventions Artesunate or dihydroartemisinin-piperaquine

Updated 5 times since 2017 Last updated: Sep 14, 2011 Started: Aug 31, 2010 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Malaria, this trial is completed. The trial is conducted by Oxford University Clinical Research Unit, Vietnam and has accumulated 5 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oxford University Clinical Research Unit, Vietnam
World Health Organization

Data source: Oxford University Clinical Research Unit, Vietnam

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dong Xoai, Vietnam